您的购物车当前为空
GKI-1是 Greatwall (GWL)激酶抑制剂,对 hGWLFL 具有抑制,其 IC50为4.9。GKI-1对 hGWL-KinDom 也具有抑制作用,其 IC50 为 2.5 µM。GKI-1 对 ROCK1抑制效果比 hGWLFL 和hGWL-KinDom 好,其IC50为11 µM, 仅微弱抑制 PKA。

GKI-1是 Greatwall (GWL)激酶抑制剂,对 hGWLFL 具有抑制,其 IC50为4.9。GKI-1对 hGWL-KinDom 也具有抑制作用,其 IC50 为 2.5 µM。GKI-1 对 ROCK1抑制效果比 hGWLFL 和hGWL-KinDom 好,其IC50为11 µM, 仅微弱抑制 PKA。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 893 | 现货 | |
| 5 mg | ¥ 2,230 | 现货 | |
| 10 mg | ¥ 3,230 | 现货 | |
| 25 mg | ¥ 5,010 | 现货 | |
| 50 mg | ¥ 6,720 | 现货 | |
| 100 mg | ¥ 9,100 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,470 | 现货 |
GKI-1 相关产品
| 产品描述 | GKI-1 is a Greatwall (GWL) kinase inhibitor that inhibits hGWLFL with an IC50 of 4.9. GKI-1 also inhibited hGWL-KinDom, and its IC50 was 2.5 µM. The inhibitory effect of GKI-1 on ROCK1 was better than that of hGWLFL and hGWL-KinDom, and its IC50 was 11 µM, which only weakly inhibited PKA. |
| 靶点活性 | GWL-KinDom (human):4.9 µM , ROCK1:11 µM, GWLFL (human):4.9 µM , GWLFL (human):4.9 µM, GWL-KinDom (human):2.5 µM |
| 体外活性 | Treatment of HeLa cells with GKI-1 (25 and 50µM, 0-8.5 h) reduced ENSA/ARPP19 phosphorylation levels, resulting in reduced mitotic events, mitotic arrest/cell death, and cell division failure. GKI-1 inhibited full-length human GWL and showed cellular effects[1] |
| 分子量 | 269.73 |
| 分子式 | C15H12ClN3 |
| CAS No. | 2444764-03-6 |
| Smiles | N(C=1C=C(C=CC1)C=2C=NNC2)C3=CC=C(Cl)C=C3 |
| 密度 | 1.320 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 180 mg/mL (667.33 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (18.54 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容